These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


188 related items for PubMed ID: 23484590

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Characterization of mechanisms of fluconazole resistance in a Candida albicans isolate from a Japanese patient with chronic mucocutaneous candidiasis.
    Kamai Y, Maebashi K, Kudoh M, Makimura K, Naka W, Uchida K, Yamaguchi H.
    Microbiol Immunol; 2004; 48(12):937-43. PubMed ID: 15611610
    [Abstract] [Full Text] [Related]

  • 28. Evaluation of fluconazole resistance mechanisms in candida albicans clinical isolates from HIV-infected patients in Brazil.
    Goldman GH, da Silva Ferreira ME, dos Reis Marques E, Savoldi M, Perlin D, Park S, Godoy Martinez PC, Goldman MH, Colombo AL.
    Diagn Microbiol Infect Dis; 2004 Sep; 50(1):25-32. PubMed ID: 15380275
    [Abstract] [Full Text] [Related]

  • 29. Epidemiology and Molecular Basis of Resistance to Fluconazole Among Clinical Candida parapsilosis Isolates in Kuwait.
    Asadzadeh M, Ahmad S, Al-Sweih N, Khan Z.
    Microb Drug Resist; 2017 Dec; 23(8):966-972. PubMed ID: 28353392
    [Abstract] [Full Text] [Related]

  • 30. [Analysis of ERG11 gene mutation in Candida albicans].
    Wang YB, Wang H, Guo HY, Zhao YZ, Luo SQ.
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Nov; 25(11):1390-3. PubMed ID: 16305963
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Amino acid substitutions in the cytochrome P-450 lanosterol 14alpha-demethylase (CYP51A1) from azole-resistant Candida albicans clinical isolates contribute to resistance to azole antifungal agents.
    Sanglard D, Ischer F, Koymans L, Bille J.
    Antimicrob Agents Chemother; 1998 Feb; 42(2):241-53. PubMed ID: 9527767
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Stepwise emergence of azole, echinocandin and amphotericin B multidrug resistance in vivo in Candida albicans orchestrated by multiple genetic alterations.
    Jensen RH, Astvad KM, Silva LV, Sanglard D, Jørgensen R, Nielsen KF, Mathiasen EG, Doroudian G, Perlin DS, Arendrup MC.
    J Antimicrob Chemother; 2015 Sep; 70(9):2551-5. PubMed ID: 26017038
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Molecular epidemiology, antifungal susceptibility, and ERG11 gene mutation of Candida species isolated from vulvovaginal candidiasis: Comparison between recurrent and non-recurrent infections.
    Esfahani A, Omran AN, Salehi Z, Shams-Ghahfarokhi M, Ghane M, Eybpoosh S, Razzaghi-Abyaneh M.
    Microb Pathog; 2022 Sep; 170():105696. PubMed ID: 35921954
    [Abstract] [Full Text] [Related]

  • 40. Changes in susceptibility to posaconazole in clinical isolates of Candida albicans.
    Li X, Brown N, Chau AS, López-Ribot JL, Ruesga MT, Quindos G, Mendrick CA, Hare RS, Loebenberg D, DiDomenico B, McNicholas PM.
    J Antimicrob Chemother; 2004 Jan; 53(1):74-80. PubMed ID: 14657086
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 10.